Cupid Ltd March 2026: Revenue Skyrockets 116% as New Management Ignites Massive FMCG and Export Scale-up
Section 1 — At a Glance
Cupid Ltd has recorded a historic structural turnaround for the financial year ended March 31, 2026, driven by an explosive multi-channel expansion across international institutional markets and domestic retail ecosystems. Total income for the fiscal year surged to ₹391.40 crore, representing a phenomenal 92.63% growth compared to ₹203.18 crore in the previous fiscal year. This top-line acceleration translated into an even steeper trajectory in operating profitability; earnings before interest, tax, depreciation, and amortization (EBITDA) leaped 179.69% to ₹116.70 crore. Net profit after tax expanded to a record ₹108.23 crore, up 164.71% against ₹40.89 crore in the prior year. The exceptional operating leverage achieved during the year is further demonstrated by the company’s full-year net profit margin expanding from 22.28% to 30.26%.
What is rapidly captivating investor attention is the aggressive pivot under a refreshed promoter group. The company has expanded its traditional business model through a massive strategic investment in regional retail distribution networks while securing core export visibility via large-scale long-term international procurement allocations. The deployment of internal accruals into synergistic retail platforms positions the consumer business as an imminent high-margin growth driver. However, this rapid metamorphosis requires careful assessment. The explosive scaling has triggered substantial capital expenditures and working capital deployments. Raw material consumption costs grew 119.98% to ₹148.14 crore during the year, and the balance sheet exhibits a sharp accumulation in inventory and trade receivables. Furthermore, the equity base has expanded through corporate actions, altering historic return ratios. Extraordinary growth rates often demand significant short-term asset commitments, making working capital optimization the primary factor in sustaining cash generation. The market is now closely evaluating whether this operational momentum can seamlessly digest the newly built capacities.
Section 2 — Introduction
Cupid Ltd has historically occupied a specialized niche within the global personal healthcare and wellness sectors, being a trusted manufacturing partner for multi-lateral public health organizations. The company holds a unique global position as the premier manufacturer to achieve simultaneous pre-qualifications from the WHO and UNFPA for both male and female condom categories. However, the historic investment thesis around this business has completely transformed over the last 24 months. The change began in October 2023 when Columbia Petro Chem Private Limited and Mr. Aditya Kumar Halwasiya acquired a controlling 41.84% stake in the entity, introducing a clean corporate transition and an aggressive expansion blueprint.
This analysis is prompted by the publication of the March 2026 financial results, which demonstrate that the growth promises made by the new management are materializing directly in the financial statements. The entity is fast transitioning from a pure-play contract manufacturer into an aggressive FMCG and wellness consumer platform. This transition is backed by a rapid scaling of production capacities and the establishment of vast distribution channels in both domestic and newly identified overseas territories.
Section 3 — Business Model: WTF Do They Even Do?
At its core, the company operates a dual-engine business model balancing globally certified institutional B2B contract manufacturing with a fast-emerging B2C branded consumer goods platform. The legacy engine utilizes a highly sophisticated 100,000 sq. ft. manufacturing facility in Sinnar, Nashik, producing male condoms, female condoms, and water-based personal lubricants. The operational efficiency of this segment is insulated by long-term procurement frameworks with international public health bodies like the WHO, UNFPA, and the Global Fund.
The second engine is the rapidly growing branded consumer portfolio. Management is leveraging its manufacturing infrastructure to push proprietary brands into the high-margin consumer retail market. This portfolio has expanded past traditional sexual wellness to encompass an array of personal care products, including deodorants, perfumes, talcum powder, hair oils, and skin cosmetics. The business model’s revenue distribution has shifted significantly: in the latest fiscal year, male condoms contributed 51.60% of revenue, female condoms represented 17.27%, IVD kits and lubricants held 7.11%, and the newly introduced FMCG products captured an impressive 24.01%. This structural shift mitigates historical tender-dependency risks by capturing last-mile consumer wallets across more than 150,000 retail endpoints.
Section 4 — Financials Overview
Figures are consolidated, in ₹ crore.
The quarterly performance shows an accelerating upward trajectory, underpinned by strong volume growth in the export segment and structural market penetration in the domestic business.
Comparison Table
Metric
Latest Quarter (Mar 2026)
YoY
QoQ
Revenue
132.04
+116.07%
+26.48%
EBITDA
37.52
+179.93%
+9.37%
PAT
36.26
+213.94%
+10.31%
EPS (₹)
0.27
+200.00%
+12.50%
Note: Quarterly revenue numbers correspond to Total Income, and EBITDA is calculated as PBT + Interest + Depreciation to maintain consistent operational comparison across periods.
The outstanding performance in the latest quarter shows that operating leverage behaves like an aggressive spring when factory utilization passes break-even thresholds. Quarterly net profit jumped from ₹11.51 crore to ₹36.26 crore on a year-on-year basis, outpacing top-line expansion as fixed overhead costs were efficiently absorbed across larger manufacturing volumes.
What is Management Promising in the Coming Quarters?
Reviewing the forward guidance shared during the May 2026 management discussions, the leadership team exhibits absolute confidence in their multi-year expansion program. Management has formalized a clear revenue target of ₹600 crore for FY27, with a commitment to maintain net profit margins above 30%. Over the longer-term horizon, the guidance maps out an escalation to ₹875 crore in revenue for FY28, reaching ₹1,150 crore by FY29, with projected net profits touching ₹275 crore and ₹390 crore respectively.